• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 6-K filed by TIAN RUIXIANG Holdings Ltd

    8/21/25 4:00:36 PM ET
    $TIRX
    Specialty Insurers
    Finance
    Get the next $TIRX alert in real time by email
    6-K 1 tm2524028d2_6k.htm FORM 6-K

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 6-K

     

    REPORT OF FOREIGN PRIVATE ISSUER

    PURSUANT TO RULE 13a-16 OR 15d-16

    UNDER THE SECURITIES EXCHANGE ACT OF 1934

     

    For the month of August 2025

     

    Commission File Number: 001- 39925

     

    TIAN RUIXIANG Holdings Ltd

     

    Room 918, Jingding Building,

    Xicheng District, District, Beijing,

    People’s Republic of China

    (Address of principal executive offices)

     

    Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40- F.

     

    Form 20-F x Form 40-F ¨

     

     

     

     

    Results of TIAN RUIXIANG Holdings Ltd.’s Extraordinary General Meeting

     

    of Shareholders on August 18, 2025

     

    An Extraordinary General Meeting of Shareholders (the “Meeting”) of TIAN RUIXIANG Holdings Ltd. (the “Company”) was held at Room 918, Jingding Building, Xicheng District, Beijing, People’s Republic of China on August 18, 2025, at 10:00 a.m. Beijing Time, pursuant to notice duly given.

     

    At the close of business on August 4, 2025, the record date for the determination of shareholders of the Company entitled to vote at the Meeting, there were 120,757,154 shares of Class A ordinary shares (each share being entitled to one (1) vote), and 1,050,000 shares of Class B ordinary shares outstanding (each share being entitled to six hundred (600) votes). At the Meeting, the holders of (1) 107,313,027 shares of Class A ordinary Shares, and (2) 1,050,000 shares of Class B ordinary shares, representing a total of 750,757,154 votes, were represented in person or by proxy, constituting a quorum.

     

    The shareholders adopted the following resolution (“Resolution 1”) at the Meeting:

    1.with immediate effect upon the commencement of the fifth business day following the passing of the ordinary resolution or such later date as the Board of Directors may determine in its sole discretion:

     

    a.All the issued and authorised but unissued shares of the Company (collectively, the Shares) to be consolidated as follows:
    i.every five (5) class A ordinary shares of a par value of US$0.025 each into one (1) class A ordinary share of a par value of US$0.125 each; and

     

     

     

     

     

    ii.every five (5) class B ordinary shares of a par value of US$0.025 each into one (1) class B ordinary share of a par value of US$0.125 each,

    with such consolidated Shares having the same rights and being subject to the same restrictions (save as to par value) as the existing Shares of such class as set out in the Company’s memorandum and articles of association (the Share Consolidation);

     

    b.as a result of the Share Consolidation, the authorised share capital of the Company will be amended from US$200,000,000 consisting of 8,000,000,000 shares comprising of (i) 7,600,000,000 class A ordinary shares of a par value of US$0.025 each, and (ii) 400,000,000 class B ordinary shares of a par value of US$0.025 each, to US$200,000,000 consisting of 1,600,000,000 shares comprising of (i) 1,520,000,000 class A ordinary shares of a par value of US$0.125 each, and (ii) 80,000,000 class B ordinary shares of a par value of US$0.125 each; and

     

    c.no fractional Shares be issued in connection with the Share Consolidation and, in the event that a shareholder would otherwise be entitled to receive a fractional Share upon the Share Consolidation, the total number of Shares to be received by such shareholder be rounded up to the next whole number of Share.

     

    At the Meeting, the Votes for Resolution 1 were as follows:

     

    Class

    Votes For

    (Shares)

    Voting Power For

    Votes Against

    (Shares)

    Voting

    Power

    Against

    Votes

    Abstain/

    Withhold

    (Shares)

    Voting

    Power

    Abstain/

    Withhold

    Total Voting

    Power (per class)

    Class A 107,249,995 107,249,995 57,512 57,512 5,520 5,520 120,757,154

    Class B  

    1,050,000 630,000,000 0 0 0 0 630,000,000
    Total 108,299,995 737,249,995 57,512 57,512 5,520 5,520 750,757,154

      

    Percentages of Total Voting Power (750,757,154)

     

    •For: 98.20%
    •Against: 0.01%
    •Abstain/Withhold: 0.00%

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

     

        TIAN RUIXIANG Holdings Ltd
           
      Date: August 21, 2025 By: /s/ Sheng Xu
        Name: Sheng Xu
        Title: Chief Executive Officer

     

     

     

    Get the next $TIRX alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $TIRX

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $TIRX
    SEC Filings

    View All

    SEC Form 6-K filed by TIAN RUIXIANG Holdings Ltd

    6-K - TIAN RUIXIANG HOLDINGS LTD (0001782941) (Filer)

    9/3/25 1:04:21 PM ET
    $TIRX
    Specialty Insurers
    Finance

    Amendment: SEC Form 6-K/A filed by TIAN RUIXIANG Holdings Ltd

    6-K/A - TIAN RUIXIANG HOLDINGS LTD (0001782941) (Filer)

    8/29/25 4:12:47 PM ET
    $TIRX
    Specialty Insurers
    Finance

    SEC Form 6-K filed by TIAN RUIXIANG Holdings Ltd

    6-K - TIAN RUIXIANG HOLDINGS LTD (0001782941) (Filer)

    8/26/25 4:45:22 PM ET
    $TIRX
    Specialty Insurers
    Finance

    $TIRX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    TIAN RUIXIANG Holdings Ltd. Announces Reverse Stock Split with Marketplace Effective Date on September 5, 2025

    BEIJING, Sept. 02, 2025 (GLOBE NEWSWIRE) -- TIAN RUIXIANG Holdings Ltd. (NASDAQ:TIRX) (the "Company") today announced that it will implement a reverse stock split of its ordinary shares at a ratio of five (5) to one (1), The Company's ordinary shares will begin trading on a split-adjusted basis on the Nasdaq Capital Market at that time under the same ticker symbol, TIRX, effective at the open of business on September 5, 2025. As part of the reverse stock split, the par value of the Company's Class A and Class B ordinary shares will be increased from US$0.025 per share to US$0.125 per share. No fractional shares will be issued in connection with the reverse stock split, and any fractional

    9/2/25 8:00:00 AM ET
    $TIRX
    Specialty Insurers
    Finance

    Water Tower Research Publishes Initiation of Coverage Report on Tian Ruixiang Holdings Limited, "From Traditional Insurance Broker to Tech-Based Health Insurance Innovator"

    ST. PETERSBURG, FL, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Water Tower Research (www.watertowerresearch.com) has published an Initiation of Coverage Report on Tian Ruixiang Holdings Limited (NASDAQ:TIRX) titled, "From Traditional Insurance Broker to Tech- Based Health Insurance Innovator". The report can be accessed here. Access to China's growing health insurance market. On June 30, 2025, Chinese insurance broker Tian Ruixiang Holdings Limited completed the acquisition of Ucare, which describes itself as the only cloud-based healthcare value assessment and insurance risk control SaaS platform in China, for total all-stock consideration of $150 million. Ucare's wealth of AI-driven analytics st

    8/7/25 12:00:00 PM ET
    $TIRX
    Specialty Insurers
    Finance

    TIAN RUIXIANG Holdings Ltd Completes Acquisition of Ucare Inc., Marking Strategic Expansion into AI-Powered Health Insurance Solutions

    BEIJING, June 30, 2025 (GLOBE NEWSWIRE) -- TIAN RUIXIANG Holdings Ltd (NASDAQ:TIRX) (the "Company" or "TRX"), a China-based insurance broker, today announced it has completed the acquisition of 100% of issued and outstanding shares of Ucare Inc. ("Ucare"), the sole operator of China's only cloud-based AI-driven hospital and health insurance risk management platform. The all-stock transaction, valued at US$150 million, marks a major milestone in TRX's strategy to expand into in-hospital distribution channels and capture new growth opportunities within the health insurance sector. As part of the closing, TRX has issued 101,486,575 Class A ordinary shares, each with a par value of US$0.025

    6/30/25 3:05:00 PM ET
    $TIRX
    Specialty Insurers
    Finance

    $TIRX
    Leadership Updates

    Live Leadership Updates

    View All

    TIAN RUIXIANG Holdings Ltd to Acquire Ucare Inc. in US$150 Million All-Stock Deal, Advancing In-Hospital Health Insurance Strategy

    BEIJING, May 30, 2025 (GLOBE NEWSWIRE) -- TIAN RUIXIANG Holdings Ltd (NASDAQ:TIRX) (the "Company" or "TRX"), a China-based insurance broker, today announced plans to acquire 100% of issued and outstanding shares of Ucare Inc. ("Ucare"), the sole operator of China's only cloud-based AI-driven hospital and health insurance risk management platform, in an all-share deal valued at US$150 million. This strategic move aims to unlock new growth opportunities in the health insurance segment. The Company and its wholly-owned subsidiary, VitaCare Limited ("VitaCare") have entered into a share exchange agreement (the "Agreement") with certain shareholders (the "Sellers") of Ucare and other parties.

    5/30/25 6:10:00 AM ET
    $TIRX
    Specialty Insurers
    Finance

    $TIRX
    Financials

    Live finance-specific insights

    View All

    Water Tower Research Publishes Initiation of Coverage Report on Tian Ruixiang Holdings Limited, "From Traditional Insurance Broker to Tech-Based Health Insurance Innovator"

    ST. PETERSBURG, FL, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Water Tower Research (www.watertowerresearch.com) has published an Initiation of Coverage Report on Tian Ruixiang Holdings Limited (NASDAQ:TIRX) titled, "From Traditional Insurance Broker to Tech- Based Health Insurance Innovator". The report can be accessed here. Access to China's growing health insurance market. On June 30, 2025, Chinese insurance broker Tian Ruixiang Holdings Limited completed the acquisition of Ucare, which describes itself as the only cloud-based healthcare value assessment and insurance risk control SaaS platform in China, for total all-stock consideration of $150 million. Ucare's wealth of AI-driven analytics st

    8/7/25 12:00:00 PM ET
    $TIRX
    Specialty Insurers
    Finance

    TIAN RUIXIANG Holdings Ltd Completes Acquisition of Ucare Inc., Marking Strategic Expansion into AI-Powered Health Insurance Solutions

    BEIJING, June 30, 2025 (GLOBE NEWSWIRE) -- TIAN RUIXIANG Holdings Ltd (NASDAQ:TIRX) (the "Company" or "TRX"), a China-based insurance broker, today announced it has completed the acquisition of 100% of issued and outstanding shares of Ucare Inc. ("Ucare"), the sole operator of China's only cloud-based AI-driven hospital and health insurance risk management platform. The all-stock transaction, valued at US$150 million, marks a major milestone in TRX's strategy to expand into in-hospital distribution channels and capture new growth opportunities within the health insurance sector. As part of the closing, TRX has issued 101,486,575 Class A ordinary shares, each with a par value of US$0.025

    6/30/25 3:05:00 PM ET
    $TIRX
    Specialty Insurers
    Finance

    TIAN RUIXIANG Holdings Ltd Reports Financial Results for the Half Year Ended April 30, 2024

    BEIJING, Aug. 16, 2024 (GLOBE NEWSWIRE) -- TIAN RUIXIANG Holdings Ltd (NASDAQ:TIRX) (the "Company"), a China-based insurance broker conducting business through its variable interest entity in China, today announced its financial results for the half year ended April 30, 2024. Ms. Sheng Xu, the Chief Executive Officer of the Company, commented, "The Company reported a net loss of approximately $2.6 million for the six months ended April 30, 2024, primarily due to a significant decline in revenue caused by the loss of a few key insurance company partners. However, we are encouraged by the increase in the commissions from liability insurance of approximately $24,000 compared to t

    8/16/24 4:15:15 PM ET
    $TIRX
    Specialty Insurers
    Finance

    $TIRX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by TIAN RUIXIANG Holdings Ltd

    SC 13G/A - TIAN RUIXIANG HOLDINGS LTD (0001782941) (Subject)

    11/13/24 11:16:48 AM ET
    $TIRX
    Specialty Insurers
    Finance

    SEC Form SC 13D filed by TIAN RUIXIANG Holdings Ltd

    SC 13D - TIAN RUIXIANG HOLDINGS LTD (0001782941) (Subject)

    6/10/24 6:15:45 AM ET
    $TIRX
    Specialty Insurers
    Finance

    SEC Form SC 13D/A filed by TIAN RUIXIANG Holdings Ltd (Amendment)

    SC 13D/A - TIAN RUIXIANG HOLDINGS LTD (0001782941) (Subject)

    6/10/24 6:08:20 AM ET
    $TIRX
    Specialty Insurers
    Finance